Literature DB >> 22197180

Diabetes mellitus and thrombosis.

Natale Vazzana1, Paola Ranalli, Chiara Cuccurullo, Giovanni Davì.   

Abstract

Atherothrombosis is the leading cause of morbidity and mortality in patients with diabetes mellitus. Several mechanisms contribute to the diabetic prothrombotic state, including endothelial dysfunction, coagulative activation and platelet hyper-reactivity. In particular, diabetic platelets are characterised by dysregulation of several signaling pathways leading to enhanced adhesion, activation and aggregation. These alterations result from the interaction among hyperglycemia, insulin resistance, inflammation and oxidative stress. This review will provide an overview of the current status of knowledge on mechanisms of accelerated atherothrombosis in patients with diabetes mellitus.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22197180     DOI: 10.1016/j.thromres.2011.11.052

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  64 in total

Review 1.  Insulin resistance in ischemic stroke.

Authors:  Xiao-Ling Deng; Zhou Liu; Chuanling Wang; Yanfeng Li; Zhiyou Cai
Journal:  Metab Brain Dis       Date:  2017-06-21       Impact factor: 3.584

2.  [Bilateral simultaneous central retinal vein occlusion in protein S deficiency].

Authors:  G Tóth; G L Sándor; C Reichel; G Domján; Z Z Nagy; M Ecsedy
Journal:  Ophthalmologe       Date:  2015-11       Impact factor: 1.059

3.  Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth.

Authors:  James V Michael; Jeremy G T Wurtzel; Guang Fen Mao; A Koneti Rao; Mikhail A Kolpakov; Abdelkarim Sabri; Nicholas E Hoffman; Sudarsan Rajan; Dhanendra Tomar; Muniswamy Madesh; Marvin T Nieman; Johnny Yu; Leonard C Edelstein; Jesse W Rowley; Andrew S Weyrich; Lawrence E Goldfinger
Journal:  Blood       Date:  2017-05-12       Impact factor: 22.113

4.  The role of diabetes mellitus on the thrombus composition in patients with acute ischemic stroke.

Authors:  Gengfan Ye; Qun Gao; Peng Qi; Junjie Wang; Shen Hu; Kunpeng Chen; Tianhua Tan; Jun Lu; Daming Wang
Journal:  Interv Neuroradiol       Date:  2020-01-10       Impact factor: 1.610

Review 5.  Targeting Select Cellular Stress Pathways to Prevent Hyperglycemia-Related Complications: Shifting the Paradigm.

Authors:  Arshag D Mooradian
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

6.  Inhibition of pyruvate dehydrogenase complex activity by 3-bromopyruvate affects blood platelets responses in type 2 diabetes.

Authors:  Anna Michno; Katarzyna Grużewska; Hanna Bielarczyk; Marlena Zyśk; Andrzej Szutowicz
Journal:  Pharmacol Rep       Date:  2020-01-10       Impact factor: 3.024

Review 7.  Pathogenesis of diabetic cerebral vascular disease complication.

Authors:  Ren-Shi Xu
Journal:  World J Diabetes       Date:  2015-02-15

8.  Patterns and levels of platelet glycosylation in patients with coronary heart disease and type 2 diabetes mellitus.

Authors:  Liping Li; Chenxue Qu; Xuelian Wu; Juhua Dai; Yao Lu; Yan Gong; Ran You; Yaqi Liu
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

9.  Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing's disease.

Authors:  Mattia Barbot; Valentina Guarnotta; Marialuisa Zilio; Filippo Ceccato; Alessandro Ciresi; Andrea Daniele; Giuseppe Pizzolanti; Elena Campello; Anna Chiara Frigo; Carla Giordano; Carla Scaroni
Journal:  Endocrine       Date:  2018-07-06       Impact factor: 3.633

Review 10.  Role of plasma kallikrein in diabetes and metabolism.

Authors:  E P Feener; Q Zhou; W Fickweiler
Journal:  Thromb Haemost       Date:  2013-05-16       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.